MLCL — Molecule Holdings Income Statement
0.000.00%
Last trade - 00:00
- CA$0.49m
- CA$6.18m
- CA$1.97m
2018 October 31st | 2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.455 | 1.97 |
Cost of Revenue | |||||
Gross Profit | — | — | — | -0.5 | -1.07 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.292 | 0.21 | 3.27 | 3.86 | 5.83 |
Operating Profit | -0.292 | -0.21 | -3.27 | -3.4 | -3.86 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.346 | -2.92 | -3.33 | -4.23 | -4.54 |
Net Income After Taxes | -0.346 | -2.92 | -3.33 | -4.23 | -4.54 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.346 | -2.92 | -3.33 | -4.23 | -4.54 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.346 | -2.92 | -3.33 | -4.23 | -4.54 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.037 | -0.352 | -0.027 | -0.045 | -0.047 |
Dividends per Share |